ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $510K of Zentalis Pharmaceuticals, Inc.
Sold$510,198
$51.02Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Tue, Aug 3 close, $51.28
- +43.3%
- S&P 500, same days
- +1.5%
Measured over 30 trading days, to the Sep 15 close.
Traded Mon, Aug 2. Filed Tue, Aug 3, 3:59 PM ET, during the session. Returns use the Aug 3 close and the Sep 15 close. Not investment advice.